Clinical Trials
4 trialsNCT07199959 2025-09-30
Study on the Mechanism of Acquired Resistance of Entrectinib
Fudan University
Recruiting
NCT06694129 2024-11-19
Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC
National Cancer Center, China
Not yet recruiting
NCT04322890 2024-10-22
PIKACHU
Hunan Province Tumor Hospital
Phase 2 Recruiting
NCT04591431 2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2 Unknown